Antitumoural hydroxyapatite nanoparticles-mediated hepatoma-targeted trans-arterial embolization gene therapy: in vitro and in vivo studies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Antitumoural hydroxyapatite nanoparticles-mediated hepatoma-targeted trans-arterial embolization gene therapy: in vitro and in vivo studies

Published:2012-02-19 Issue:6 Volume:32 Page:998-1007
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Li Gaopeng¹,Ye Lu²,Pan Jingsheng¹,Long Miaoyun³,Zhao Zizhuo¹,Yang Haiyun¹,Tian Jing¹,Wen Yanling¹,Dong Shengli⁴,Guan Jian⁵,Luo Baoming¹

Affiliation:

1. Department of Ultrasound; Sun Yat-Sen Memorial Hospital; Sun Yat-Sen University; Guangzhou; Guangdong Province; China

2. Infection Department; Guangzhou No.8 Hospital; Guangzhou; Guangdong Province; China

3. Department of Thyroid and Vascular Disease Surgery; Sun Yat-Sen Memorial Hospital; Sun Yat-Sen University; Guangzhou; Guangdong Province; China

4. Department of General Surgery; The Second Affiliated Hospital; Shanxi Medical University; Taiyuan; Shanxi Province; China

5. Radiology Department; The First Affiliated Hospital; Sun Yat-Sen University; Guangzhou; Guangdong Province; China

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1478-3231.2012.02761.x/fullpdf

Reference37 articles.

1. Hepatocellular carcinoma: epidemiology and clinical aspects;Mazzanti;Mol Aspects Med,2008

2. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma;Lo;Hepatology,2002

3. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial;Llovet;Lancet,2002

4. Postoperative transhepatic arterial chemoembolization and portal vein chemotherapy for patients with hepatocellular carcinoma: a randomized study with 131 cases;Li;Dig Surg,2006

5. Chemoembolization combined with radiofrequency ablation for patients with hepatocellular carcinoma larger than 3 cm: a randomized controlled trial;Cheng;JAMA,2008

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanocrystal hydroxyapatite carrying traditional Chinese medicine for osteogenic differentiation;Colloids and Surfaces B: Biointerfaces;2024-12

2. Harnessing the power of hydroxyapatite nanoparticles for gene therapy;Applied Materials Today;2024-08

3. Role and importance of hydroxyapatite in the healthcare sector;Industrial Applications of Nanoceramics;2024

4. Synergistic effect of OK-432 in combination with an anti-PD-1 antibody for residual tumors after radiofrequency ablation of hepatocellular carcinoma;Biomedicine & Pharmacotherapy;2023-10

5. The Role of Selenium Nanoparticles in the Treatment of Liver Pathologies of Various Natures;International Journal of Molecular Sciences;2023-06-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3